FDA Shuts Down Arthritis Advisory Committee for Good
Published Date: 8/29/2025
Rule
Summary
The FDA is officially ending the Arthritis Advisory Committee and removing it from their list of active advisory groups. This means the committee won’t meet or advise the FDA anymore, but no new costs or deadlines are involved. Anyone interested in arthritis drug advice will see this change take effect right away.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in